End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 SEK | -.--% | -.--% | +3.45% |
Apr. 17 | Peptonic Medical Plans SEK61 Million Shares, Warrants Issue | MT |
Apr. 15 | Peptonic Medical Secures US Patent for Vaginal Yeast Infections Treatment | MT |
Business Summary
Number of employees: 32
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Oxytocin Based Products
100.0
%
| 32 | 100.0 % | 44 | 100.0 % | +37.89% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 32 | 100.0 % | 44 | 100.0 % | +37.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Erik Sundquist
CEO | Chief Executive Officer | 54 | 21-04-13 |
Albert Lindgren
DFI | Director of Finance/CFO | - | 23-10-20 |
Hadar Kessary
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 64 | 08-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tarek Shoeb
BRD | Director/Board Member | 55 | 23-05-23 |
Karl Blom
BRD | Director/Board Member | 55 | - |
Anders Norling
BRD | Director/Board Member | 58 | 22-05-23 |
Daniel Rudeklint
BRD | Director/Board Member | 43 | - |
Anna Stinger
BRD | Director/Board Member | - | 23-05-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,534,845,596 | 114,705,799 ( 7.473 %) | 0 | 7.473 % |
Company contact information
Peptonic Medical AB
Gustavslundsvägen 143
167 51, Bromma
+46 8 53 02 01 10
http://www.peptonicmedical.seSector
1st Jan change | Capi. | |
---|---|---|
+3.45% | 8.4M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PMED Stock
- Company PEPTONIC medical AB